Moreover, blocking TLR2 signaling retards tumor metastasis and prolongs the survival of tumor-bearing mice largely associated to the reversal of the tumor cell-induced immunosuppressive microenvironment and the restoration of tumor-killing cells, such as CD8+ T cells and M1 cells. Here, CD8A is linked to neoplasm.